WASHINGTON — President Trump is expected to deliver a major address on drug prices this week. And perhaps more than with any other president, Washington is wondering: What will he say?
There’s the version of the speech that top health officials have been touting and previewing for the last several weeks — the serious, “comprehensive strategy” that will result in a “profound modernization” of how the federal government pays for at least some drugs, to hear health secretary Alex Azar or FDA Commissioner Scott Gottlieb tell it.
But neither of those men will be behind the teleprompter this week. Because this is Trump, there is another possible version of the speech on everyone’s minds: the version in which he rips up his speech or otherwise ventures off script.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.